REFRACTORY SOLID TUMORS
Clinical trials for REFRACTORY SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOLID TUMORS trials appear
Sign up with your email to follow new studies for REFRACTORY SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: experimental drug PEEL-224 enters trials
Disease control Recruiting nowThis study tests a new drug called PEEL-224, alone or with standard chemotherapy, in children and young adults whose solid tumors have not responded to treatment or have returned. The first part finds the safest dose, and the second part measures how well the drug combination shr…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Theodore Laetsch • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New hope for kids with resistant cancers: drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a three-drug combination (eribulin, irinotecan, and temozolomide) in children and young adults up to age 25 whose solid tumors have returned or not responded to standard treatment. The main goal is to find a safe dose and watch for side effects. About…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
Scientists launch massive effort to decode rare tumors
Knowledge-focused Recruiting nowThis study aims to better understand rare solid tumors by collecting biological samples (like blood, saliva, and tumor tissue) and health information from up to 10,000 people over many years. Participants include people with a rare tumor, those with a genetic risk for one, and th…
Matched conditions: REFRACTORY SOLID TUMORS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC